Standard Biotools (LAB) Depreciation and Depletion (2023 - 2026)

Standard Biotools (LAB) has 4 years of Depreciation and Depletion data on file, last reported at $1.4 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $1.4 million, down 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (up 26.53% YoY), and the FY2025 annual result was $6.9 million, up 81.58% from the prior year.
• Depreciation and Depletion improved to $1.4 million in Q1 2026 per LAB's latest filing, from $1.3 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $3.0 million in Q1 2024 and troughed at $700000.0 in Q1 2023.
• A 4-year average of $1.5 million and a median of $1.3 million in 2025 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2024 and 2026: Depreciation and Depletion surged 328.57% in 2024, then plunged 33.33% in 2026.
• A 4-year view of Depreciation and Depletion shows it stood at $700000.0 in 2023, then grew by 14.29% to $800000.0 in 2024, then soared by 62.5% to $1.3 million in 2025, then increased by 7.69% to $1.4 million in 2026.
• Business Quant data shows LAB's Depreciation and Depletion at $1.4 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.